Translational Medicine Predoctoral Fellowship supports doctoral students’ thesis research translating discoveries into diagnostic, therapeutic, and computational approaches to address unmet clinical needs.
Funder: PhRMA Foundation
Due Dates: October 30, 2026, noon ET (Second-cycle LOI) | November 6, 2026 (First-cycle invited application) | March 2027 (Second-cycle invited application; exact deadline upon invitation)
Funding Amounts: $30,000 per year in stipend support for 12, 18, or 24 months
Summary: Supports advanced doctoral thesis research translating discoveries into diagnostic, therapeutic, and computational approaches addressing unmet clinical needs.
Key Information: Only one applicant per lab may apply to Translational Medicine, choosing either a predoctoral or postdoctoral applicant.
The PhRMA Foundation’s Translational Medicine Predoctoral Fellowship supports students in advanced training and thesis research at accredited U.S. universities. The program seeks therapeutically relevant, hypothesis-driven research that moves laboratory discoveries toward human applications and uses clinical findings to inform further laboratory work. Its priority is identifying unmet clinical needs and developing approaches that improve disease prevention, diagnosis, treatment, and patient care.
Supported areas include innovative diagnostics and therapeutics in human-relevant models, precision medicine, surrogate and digital clinical endpoints, and experimental or computational methods that reduce animal testing. Other areas include biologically validated modeling and simulation, translational pharmacokinetics and pharmacodynamics, and target or biomarker validation using human data. Applicants are expected to work with clinical collaborators to identify unmet needs.